Comprehensive transcriptomic analysis of molecularly targeted drugs in cancer for target pathway evaluation
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comprehensive transcriptomic analysis of molecularly targeted drugs in cancer for target pathway evaluation
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume 106, Issue 7, Pages 909-920
Publisher
Wiley
Online
2015-04-24
DOI
10.1111/cas.12682
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug Discovery Approaches to Target Wnt Signaling in Cancer Stem Cells
- (2015) Oncotarget
- TRIB1 Supports Prostate Tumorigenesis and Tumor-Propagating Cell Survival by Regulation of Endoplasmic Reticulum Chaperone Expression
- (2014) Tetsuo Mashima et al. CANCER RESEARCH
- The Cell-Cycle Regulator CDK4: An Emerging Therapeutic Target in Melanoma
- (2013) K. E. Sheppard et al. CLINICAL CANCER RESEARCH
- Genome-based cancer therapeutics: targets, kinase drug resistance and future strategies for precision oncology
- (2013) Paul Workman et al. CURRENT OPINION IN PHARMACOLOGY
- Tivantinib—a cytotoxic drug in MET inhibitor's clothes?
- (2013) Paolo Michieli et al. Nature Reviews Clinical Oncology
- Bypass Mechanisms of Resistance to Receptor Tyrosine Kinase Inhibition in Lung Cancer
- (2013) M. J. Niederst et al. Science Signaling
- The molecular basis of targeting protein kinases in cancer therapeutics
- (2013) Chung-Jung Tsai et al. SEMINARS IN CANCER BIOLOGY
- Ligand-triggered resistance to molecular targeted drugs in lung cancer: Roles of hepatocyte growth factor and epidermal growth factor receptor ligands
- (2012) Seiji Yano et al. CANCER SCIENCE
- Development of a gene expression database and related analysis programs for evaluation of anticancer compounds
- (2012) Masaru Ushijima et al. CANCER SCIENCE
- CH5424802, a Selective ALK Inhibitor Capable of Blocking the Resistant Gatekeeper Mutant
- (2011) Hiroshi Sakamoto et al. CANCER CELL
- Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils
- (2011) Davide Torti et al. EMBO Molecular Medicine
- Correlating Phosphatidylinositol 3-Kinase Inhibitor Efficacy with Signaling Pathway Status:In silicoand Biological Evaluations
- (2010) Shingo Dan et al. CANCER RESEARCH
- Tyrosine Kinases as Molecular Targets to Inhibit Cancer Progression and Metastasis
- (2010) V. Cepero et al. CURRENT PHARMACEUTICAL DESIGN
- Amrubicin for the treatment of advanced lung cancer
- (2009) Takayasu Kurata Expert Opinion on Drug Metabolism & Toxicology
- Cytotoxic effects of celecoxib on Raji lymphoma cells correlate with aggravated endoplasmic reticulum stress but not with inhibition of cyclooxygenase-2
- (2009) Szu-Ting Chen et al. LEUKEMIA RESEARCH
- An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
- (2009) Teresa A. Soucy et al. NATURE
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
- (2008) Da Wei Huang et al. NUCLEIC ACIDS RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now